(Q39939627)
Statements
Activity of dasatinib, a dual SRC/ABL kinase inhibitor, and IPI-504, a heat shock protein 90 inhibitor, against gastrointestinal stromal tumor-associated PDGFRAD842V mutation (English)
Maria Debiec-Rychter
Peter Marynen
Raf Sciot
Patrick Schöffski
1 September 2008